comparison of twice-daily exenatide and biphasic insulin aspart in patients with type 2 diabetes who were suboptimally controlled with sulfonylurea and metformin: a non-inferiority... von Nauck, M. A, Duran, S, Kim, D, Johns, D, Northrup, J, Festa, A, Brodows, R, Trautmann, M

Volltext

Long-term effects of exenatide therapy over 82 weeks on glycaemic control and weight in over-weight metformin-treated patients with type 2 diabetes mellitus von Ratner, R. E., Maggs, D., Nielsen, L. L., Stonehouse, A. H., Poon, T., Zhang, B., Bicsak, T. A., Brodows, R. G., Kim, D. D.

Volltext

Effects of Exenatide on Systolic Blood Pressure in Subjects With Type 2 Diabetes von Okerson, Ted, Yan, Ping, Stonehouse, Anthony, Brodows, Robert

Volltext

Efficacy and tolerability of exenatide monotherapy over 24 weeks in antidiabetic drug—naive patients with type 2 diabetes: A randomized, double-blind, placebo-controlled, parallel-... von Moretto, Thomas J., MD, Milton, Denái R., MS, Ridge, Terry D., MSN, MacConell, Leigh A., PhD, Okerson, Ted, MD, Wolka, Anne M., PhD, Brodows, Robert G., MD

Volltext

Response to comment on: Nauck MA, Duran S, Kim D et al (2007) A comparison of twice-daily exenatide and biphasic insulin aspart in patients with type 2 diabetes who were suboptimal... von Nauck, M. A., Trautman, M., Brodows, R., Johns, D., Northrup, J., Kim, D.

Volltext

P39 Facteurs prédictifs d’atteinte de l’objectif glycémique chez des patients diabétiques de type 2 traités par exénatide ou insuline : résultats d’une méta-analyse von Brodows, R, Milton, D, Salaun-Martin, C, Mao, J, Wintle, M, Trautmann, M

Volltext

PDB2 GLYCAEMIC AND WEIGHT EFFECTS OF EXENATIDE FOR DIFFERENT AGE GROUPS von Wintle, M, Guan, X, Mac, S, Brodows, R, Kim, D

Volltext

PDB5 GLYCAEMIC AND WEIGHT EFFECTS OF EXENATIDE FOR DIFFERENT AGE GROUPS von Wintle, M, Guan, X, Brodows, R, Mac, S

Volltext

Therapy focused on lowering postprandial glucose, not fasting glucose, may be superior for lowering HbA1c. IOEZ Study Group von E J Bastyr, 3rd, C A Stuart, R G Brodows, S Schwartz, C J Graf, A Zagar, K E Robertson

Volltext

Starvation enhances the ability of insulin to inhibit its own secretion von Brodows, Robert G.

Volltext

PDB5 IMPROVED TREATMENT SATISFACTION IN PATIENTS WITH TYPE-2 DIABETES TREATED WITH EXENATIDE OR INSULIN GLARGINE von Secnik, K, Hayes, C, Matza, L, Kim, S, Oglesby, A, Yurgin, N, Brodows, R, Malley, K

Volltext

Adrenergic influence on glucocounterregulation in man von Lilavivat, U, Brodows, R G, Campbell, R G

Volltext

Insulin action during acute starvation: Evidence for selective insulin resistance in normal man von Newman, William P., Brodows, Robert G.

Volltext

Control of insulin secretion during fasting in man von Lilavivathana, Usah, Campbell, R.G., Brodows, R.G.

Volltext

Therapy focused on lowering postprandial glucose, not fasting glucose, may be superior for lowering HbA1c von BASTYR, E. J, STUART, C. A, BRODOWS, R. G, SCHWARTZ, S, GRAF, C. J, ZAGAR, A, ROBERTSON, K. E

Volltext

Neural control of counter-regulatory events during glucopenia in man von Brodows, R G, Pi-Sunyer, F X, Campbell, R G

Volltext

P021 - Exenatide vs insuline glargine chez des patients diabétiques de type 2 sous metformine + sulfamide : même contrôle glycémique, baisse du poids et du nombre d’hypoglycémies n... von Heine, R., Van Gaal, L., Johns, D., Mihm, M., Salaün-Martin, C., Widel, M., Brodows, R.

Volltext

Targeting postprandial blood glucose concentrations reduced haemoglobin A1c concentrations in type 2 diabetes mellitus von Montori, V.

Volltext

P1-174 - Comparaison entre exenatide et insuline glargine chez des patients traités par un seul antidiabétique oral von Trautmann, M., Burger, J., Salaun-Martin, C., Johns, D., Kim, D., Brodows, R., Festa, A., Roberts, A., Barnett, A.

Volltext

Mechanism of plasma cyclic AMP response to hypoglycemia in man von Brodows, Robert G., Ensinck, John W., Campbell, Robert G.

Volltext